Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Corticosteroid for Knee Osteoarthritis
NCT06032039Phase 1Unknown
- Sponsor
- The University of the West Indies
- Start
- Oct 2023
- Primary completion
- Oct 2024
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of autologous platelet-rich plasma in osteoarthritis (OA) (2 arms), sponsored by The University of the West Indies. Primary endpoints: Western Ontario and McMaster Universities Arthritis Index Pain Score at 1 year, Western Ontario and McMaster Universities Arthritis Index Function Score at 1 year and 1 more. Status: unknown.
02
Drugs
autologous platelet-rich plasma
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06032039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06032039.